Literature DB >> 2539311

Fibrolamellar hepatocellular carcinoma complicating ulcerative colitis with primary sclerosing cholangitis.

J A Snook1, P Kelly, R W Chapman, D P Jewell.   

Abstract

This case report describes the previously undocumented association between fibrolamellar hepatocellular carcinoma and ulcerative colitis complicated by primary sclerosing cholangitis.

Entities:  

Mesh：

Year:  1989        PMID： 2539311      PMCID： PMC1378309          DOI： 10.1136/gut.30.2.243

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  8 in total

1.  Hepatoma associated with ulcerative colitis: Report of a case.

Authors:  P M Smith
Journal:  Dis Colon Rectum       Date:  1974 Jul-Aug       Impact factor: 4.585

2.  Biliary tract carcinoma associated with ulcerative colitis.

Authors:  J K Ritchie; R N Allan; J Macartney; H Thompson; P R Hawley; W T Cooke
Journal:  Q J Med       Date:  1974-04

Review 3.  Bile duct carcinoma in patients with ulcerative colitis. Relationship to sclerosing cholangitis: report of six cases and review of the literature.

Authors:  S H Mir-Madjlessi; R G Farmer; M V Sivak
Journal:  Dig Dis Sci       Date:  1987-02       Impact factor: 3.199

4.  High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma.

Authors:  F J Paradinas; W M Melia; M L Wilkinson; B Portmann; P J Johnson; I M Murray-Lyon; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-25

5.  Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis.

Authors:  A Wee; J Ludwig; R J Coffey; N F LaRusso; R H Wiesner
Journal:  Hum Pathol       Date:  1985-07       Impact factor: 3.466

6.  Neurotensin secretion by fibrolamellar carcinoma of the liver.

Authors:  N A Collier; K Weinbren; S R Bloom; Y C Lee; H J Hodgson; L H Blumgart
Journal:  Lancet       Date:  1984-03-10       Impact factor: 79.321

7.  Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features.

Authors:  J R Craig; R L Peters; H A Edmondson; M Omata
Journal:  Cancer       Date:  1980-07-15       Impact factor: 6.860

8.  Ulcerative colitis and persistent liver dysfunction.

Authors:  H A Shepherd; W S Selby; R W Chapman; D Nolan; C Barbatis; J O McGee; D P Jewell
Journal:  Q J Med       Date:  1983
  8 in total
  3 in total

Review 1.  Hepatic angiomyolipoma developing during the follow-up of ulcerative colitis: report of a case and review of the literature.

Authors:  S Suzuki; S Nakamura; H Ishida; T Sakaguchi; A Serizawa; H Konno; S Baba; H Muro; I Kosugi; E Gu
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

2.  Typical fibrolamellar hepatocellular carcinoma in Japanese patients: report of two cases.

Authors:  J Tanaka; N Baba; S Arii; K Fujita; J Tamura; Y Kawakami; S Tsuji; M Imamura; H Yamabe; S Nakai
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

Review 3.  Fibrolamellar carcinoma: 2012 update.

Authors:  Michael Torbenson
Journal:  Scientifica (Cairo)       Date:  2012-09-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.